Sarepta Therapeutics, Inc. (SRPT) › Operating IncomeSarepta Therapeutics, Inc. (SRPT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$15.51M2010: -$20.93M2011: -$35.93M2012: -$29.70M2013: -$90.28M2014: -$133.79M2015: -$220.18M2016: -$266.73M2017: -$171.64M2018: -$343.63M2019: -$705.56M2020: -$564.16M2021: -$459.71M2022: -$536.20M2023: -$267.82M2024: $218.08M2025: -$699.78M-$699.78M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$699.78M-420.9%2024$218.08M+181.4%2023-$267.82M+50.1%2022-$536.20M-16.6%2021-$459.71M+18.5%2020-$564.16M+20.0%2019-$705.56M-105.3%2018-$343.63M-100.2%2017-$171.64M+35.7%2016-$266.73M-21.1%2015-$220.18M-64.6%2014-$133.79M-48.2%2013-$90.28M-204.0%2012-$29.70M+17.3%2011-$35.93M-71.6%2010-$20.93M-35.0%2009-$15.51M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share